Pharmacological Effects of Zotepine and other Antipsychotics on the Central 5-HT2 Receptors
暂无分享,去创建一个
[1] G. Skuza,et al. Effects of zotepine on the central 5-HT receptor subpopulations , 1992, European Neuropsychopharmacology.
[2] R. Heel,et al. Clozapine. A review of its pharmacological properties, and therapeutic use in schizophrenia. , 1990, Drugs.
[3] P. Janssen,et al. Pilot Clinical Investigation of Risperidone in the Treatment of Psychotic Patients , 1990, Pharmacopsychiatry.
[4] A. Megens,et al. Behavioral disinhibition after risperidone in amphetamine challenged rats: a comparison with haloperidol , 1990 .
[5] H. Meltzer,et al. Classification of typical and atypical antipsychotic drugs on the basis of dopamine D-1, D-2 and serotonin2 pKi values. , 1989, The Journal of pharmacology and experimental therapeutics.
[6] C J Niemegeers,et al. Pharmacology of risperidone (R 64 766), a new antipsychotic with serotonin-S2 and dopamine-D2 antagonistic properties. , 1988, The Journal of pharmacology and experimental therapeutics.
[7] S. Yamawaki. Profiles of Clinical Efficacy and Pharmacological Action of Zotepine , 1987, Pharmacopsychiatry.
[8] H. Hinterhuber,et al. Zotepine in the Treatment of Negative Symptoms in Chronic Schizophrenia , 1987, Pharmacopsychiatry.
[9] A. Puech,et al. Classification of Neuroleptics - Zotepine , 1987, Pharmacopsychiatry.
[10] M. Ackenheil,et al. Zotepine, a Neuroleptic Drug with a Bipolar Therapeutic Profile , 1987, Pharmacopsychiatry.
[11] Y. Nomura,et al. Effects of zotepine, chlorpromazine and haloperidol on D-1, D-2, D-3 and D-4 subtypes of dopamine receptors in rat striatal and bovine caudate nucleus membranes , 1986, Neurochemistry International.
[12] S. Marder,et al. Akathisia with haloperidol and thiothixene. , 1984, Psychopharmacology bulletin.
[13] P. Janssen,et al. The head-twitch response to intraperitoneal injection of 5-hydroxytryptophan in the rat: Antagonist effects of purported 5-hydroxytryptamine antagonists and of pirenperone, an LSD antagonist , 1983, Neuropharmacology.
[14] T. Crow. Positive and Negative Schizophrenic Symptoms and the Role of Dopamine , 1980, British Journal of Psychiatry.
[15] R. Neuman,et al. Facilitation of spinal motoneurone excitability by 5-hydroxytryptamine and noradrenaline , 1980, Brain Research.
[16] G. Skuza,et al. The influence of neuroleptics on the behavioural effect of 5-hydroxytryptophan. , 1978, Polish journal of pharmacology and pharmacy.
[17] B. Przewłocka,et al. Antagonistic effect of cyproheptadine on neuroleptic-induced catalepsy , 1975, Pharmacology Biochemistry and Behavior.
[18] W. Feuerlein,et al. [Drug addiction and drug abuse]. , 1969, Munchener medizinische Wochenschrift.
[19] S. Corne,et al. A method for assessing the effects of drugs on the central actions of 5-hydroxytryptamine. , 1963, British journal of pharmacology and chemotherapy.
[20] A. Megens,et al. Pharmacological profile of the new potent neuroleptic ocaperidone (R 79,598). , 1992, The Journal of pharmacology and experimental therapeutics.
[21] S. Kanba,et al. Neuropharmacology of zotepine, an antimanic drug: a potent blocker of D2 and 5-HT2 receptors of human brain. , 1991, The Japanese journal of psychiatry and neurology.
[22] R. Glennon,et al. Multiple populations of serotonin receptors may modulate the behavioral effects of serotonergic agents. , 1991, Life sciences.
[23] C. Niemegeers,et al. Serotonin Involvement in the Action of Antipsychotic Drugs , 1990 .
[24] S. Otsuki,et al. Antimanic effect of zotepine. , 1986, Clinical therapeutics.
[25] S. Marini,et al. Neuroleptic-induced extrapyramidal side effects: clinical perspectives with ritanserin (R 55667), a new selective 5-HT2 receptor blocking agent , 1986 .
[26] H. Satoh,et al. Effect of zotepine on fenfluramine-induced hyperthermia in rats. , 1984, Japanese Journal of Pharmacology.
[27] T. Yamamoto,et al. Effect of zotepine on head-twitch induced by L-5-hydroxytryptophan, mescaline and 2,5-dimethoxy-4-methylamphetamine in mice and rats. , 1983, Japanese Journal of Pharmacology.
[28] S. Katsuki,et al. The central anti-serotonin activity of zotepine, a new neuroleptic, in rats. , 1982, Japanese journal of pharmacology.
[29] Y. Satoh,et al. Pharmacological study of [2-chloro-11-(2-dimethylaminoethoxy) dibenzo[b,f]thiepine] (zotepine), a new neuroleptic drug. , 1979, Arzneimittel-Forschung.
[30] J. Maj,et al. Influence of WA-335, a factor which blocks serotonin receptors, on neuroleptic-induced catalepsy. , 1976, Archivum immunologiae et therapiae experimentalis.
[31] S. Stahl,et al. The dopamine hypothesis of schizophrenia: a review. , 1976, Schizophrenia bulletin.